Author: MIT News

Monitoring electromagnetic signals in the brain with MRI

Anne Trafton |

Researchers commonly study brain function by monitoring two types of electromagnetism — electric fields and light. However, most methods for measuring these phenomena in the brain are very invasive.

MIT engineers have now devised a new technique to detect either electrical activity or optical signals in the brain using a minimally invasive sensor for magnetic resonance imaging (MRI).

MRI is often used to measure changes in blood flow that indirectly represent brain activity, but the MIT team has devised a new type of MRI sensor that can detect tiny electrical currents, as well as light produced by luminescent proteins. (Electrical impulses arise from the brain’s internal communications, and optical signals can be produced by a variety of molecules developed by chemists and bioengineers.)

“MRI offers a way to sense things from the outside of the body in a minimally invasive fashion,” says Aviad Hai, an MIT postdoc and the lead author of the study. “It does not require a wired connection into the brain. We can implant the sensor and just leave it there.”

This kind of sensor could give neuroscientists a spatially accurate way to pinpoint electrical activity in the brain. It can also be used to measure light, and could be adapted to measure chemicals such as glucose, the researchers say.

Alan Jasanoff, an MIT professor of biological engineering, brain and cognitive sciences, and nuclear science and engineering, and an associate member of MIT’s McGovern Institute for Brain Research, is the senior author of the paper, which appears in the Oct. 22 issue of Nature Biomedical Engineering. Postdocs Virginia Spanoudaki and Benjamin Bartelle are also authors of the paper.

Detecting electric fields

Jasanoff’s lab has previously developed MRI sensors that can detect calcium and neurotransmitters such as serotonin and dopamine. In this paper, they wanted to expand their approach to detecting biophysical phenomena such as electricity and light. Currently, the most accurate way to monitor electrical activity in the brain is by inserting an electrode, which is very invasive and can cause tissue damage. Electroencephalography (EEG) is a noninvasive way to measure electrical activity in the brain, but this method cannot pinpoint the origin of the activity.

To create a sensor that could detect electromagnetic fields with spatial precision, the researchers realized they could use an electronic device — specifically, a tiny radio antenna.

MRI works by detecting radio waves emitted by the nuclei of hydrogen atoms in water. These signals are usually detected by a large radio antenna within an MRI scanner. For this study, the MIT team shrank the radio antenna down to just a few millimeters in size so that it could be implanted directly into the brain to receive the radio waves generated by water in the brain tissue.

The sensor is initially tuned to the same frequency as the radio waves emitted by the hydrogen atoms. When the sensor picks up an electromagnetic signal from the tissue, its tuning changes and the sensor no longer matches the frequency of the hydrogen atoms. When this happens, a weaker image arises when the sensor is scanned by an external MRI machine.

The researchers demonstrated that the sensors can pick up electrical signals similar to those produced by action potentials (the electrical impulses fired by single neurons), or local field potentials (the sum of electrical currents produced by a group of neurons).

“We showed that these devices are sensitive to biological-scale potentials, on the order of millivolts, which are comparable to what biological tissue generates, especially in the brain,” Jasanoff says.

The researchers performed additional tests in rats to study whether the sensors could pick up signals in living brain tissue. For those experiments, they designed the sensors to detect light emitted by cells engineered to express the protein luciferase.

Normally, luciferase’s exact location cannot be determined when it is deep within the brain or other tissues, so the new sensor offers a way to expand the usefulness of luciferase and more precisely pinpoint the cells that are emitting light, the researchers say. Luciferase is commonly engineered into cells along with another gene of interest, allowing researchers to determine whether the genes have been successfully incorporated by measuring the light produced.

Smaller sensors

One major advantage of this sensor is that it does not need to carry any kind of power supply, because the radio signals that the external MRI scanner emits are enough to power the sensor.

Hai, who will be joining the faculty at the University of Wisconsin at Madison in January, plans to further miniaturize the sensors so that more of them can be injected, enabling the imaging of light or electrical fields over a larger brain area. In this paper, the researchers performed modeling that showed that a 250-micron sensor (a few tenths of a millimeter) should be able to detect electrical activity on the order of 100 millivolts, similar to the amount of current in a neural action potential.

Jasanoff’s lab is interested in using this type of sensor to detect neural signals in the brain, and they envision that it could also be used to monitor electromagnetic phenomena elsewhere in the body, including muscle contractions or cardiac activity.

“If the sensors were on the order of hundreds of microns, which is what the modeling suggests is in the future for this technology, then you could imagine taking a syringe and distributing a whole bunch of them and just leaving them there,” Jasanoff says. “What this would do is provide many local readouts by having sensors distributed all over the tissue.”

The research was funded by the National Institutes of Health.

Electrical properties of dendrites help explain our brain’s unique computing power

Anne Trafton |

Neurons in the human brain receive electrical signals from thousands of other cells, and long neural extensions called dendrites play a critical role in incorporating all of that information so the cells can respond appropriately.

Using hard-to-obtain samples of human brain tissue, MIT neuroscientists have now discovered that human dendrites have different electrical properties from those of other species. Their studies reveal that electrical signals weaken more as they flow along human dendrites, resulting in a higher degree of electrical compartmentalization, meaning that small sections of dendrites can behave independently from the rest of the neuron.

These differences may contribute to the enhanced computing power of the human brain, the researchers say.

“It’s not just that humans are smart because we have more neurons and a larger cortex. From the bottom up, neurons behave differently,” says Mark Harnett, the Fred and Carole Middleton Career Development Assistant Professor of Brain and Cognitive Sciences. “In human neurons, there is more electrical compartmentalization, and that allows these units to be a little bit more independent, potentially leading to increased computational capabilities of single neurons.”

Harnett, who is also a member of MIT’s McGovern Institute for Brain Research, and Sydney Cash, an assistant professor of neurology at Harvard Medical School and Massachusetts General Hospital, are the senior authors of the study, which appears in the Oct. 18 issue of Cell. The paper’s lead author is Lou Beaulieu-Laroche, a graduate student in MIT’s Department of Brain and Cognitive Sciences.

Neural computation

Dendrites can be thought of as analogous to transistors in a computer, performing simple operations using electrical signals. Dendrites receive input from many other neurons and carry those signals to the cell body. If stimulated enough, a neuron fires an action potential — an electrical impulse that then stimulates other neurons. Large networks of these neurons communicate with each other to generate thoughts and behavior.

The structure of a single neuron often resembles a tree, with many branches bringing in information that arrives far from the cell body. Previous research has found that the strength of electrical signals arriving at the cell body depends, in part, on how far they travel along the dendrite to get there. As the signals propagate, they become weaker, so a signal that arrives far from the cell body has less of an impact than one that arrives near the cell body.

Dendrites in the cortex of the human brain are much longer than those in rats and most other species, because the human cortex has evolved to be much thicker than that of other species. In humans, the cortex makes up about 75 percent of the total brain volume, compared to about 30 percent in the rat brain.

Although the human cortex is two to three times thicker than that of rats, it maintains the same overall organization, consisting of six distinctive layers of neurons. Neurons from layer 5 have dendrites long enough to reach all the way to layer 1, meaning that human dendrites have had to elongate as the human brain has evolved, and electrical signals have to travel that much farther.

In the new study, the MIT team wanted to investigate how these length differences might affect dendrites’ electrical properties. They were able to compare electrical activity in rat and human dendrites, using small pieces of brain tissue removed from epilepsy patients undergoing surgical removal of part of the temporal lobe. In order to reach the diseased part of the brain, surgeons also have to take out a small chunk of the anterior temporal lobe.

With the help of MGH collaborators Cash, Matthew Frosch, Ziv Williams, and Emad Eskandar, Harnett’s lab was able to obtain samples of the anterior temporal lobe, each about the size of a fingernail.

Evidence suggests that the anterior temporal lobe is not affected by epilepsy, and the tissue appears normal when examined with neuropathological techniques, Harnett says. This part of the brain appears to be involved in a variety of functions, including language and visual processing, but is not critical to any one function; patients are able to function normally after it is removed.

Once the tissue was removed, the researchers placed it in a solution very similar to cerebrospinal fluid, with oxygen flowing through it. This allowed them to keep the tissue alive for up to 48 hours. During that time, they used a technique known as patch-clamp electrophysiology to measure how electrical signals travel along dendrites of pyramidal neurons, which are the most common type of excitatory neurons in the cortex.

These experiments were performed primarily by Beaulieu-Laroche. Harnett’s lab (and others) have previously done this kind of experiment in rodent dendrites, but his team is the first to analyze electrical properties of human dendrites.

Unique features

The researchers found that because human dendrites cover longer distances, a signal flowing along a human dendrite from layer 1 to the cell body in layer 5 is much weaker when it arrives than a signal flowing along a rat dendrite from layer 1 to layer 5.

They also showed that human and rat dendrites have the same number of ion channels, which regulate the current flow, but these channels occur at a lower density in human dendrites as a result of the dendrite elongation. They also developed a detailed biophysical model that shows that this density change can account for some of the differences in electrical activity seen between human and rat dendrites, Harnett says.

Nelson Spruston, senior director of scientific programs at the Howard Hughes Medical Institute Janelia Research Campus, described the researchers’ analysis of human dendrites as “a remarkable accomplishment.”

“These are the most carefully detailed measurements to date of the physiological properties of human neurons,” says Spruston, who was not involved in the research. “These kinds of experiments are very technically demanding, even in mice and rats, so from a technical perspective, it’s pretty amazing that they’ve done this in humans.”

The question remains, how do these differences affect human brainpower? Harnett’s hypothesis is that because of these differences, which allow more regions of a dendrite to influence the strength of an incoming signal, individual neurons can perform more complex computations on the information.

“If you have a cortical column that has a chunk of human or rodent cortex, you’re going to be able to accomplish more computations faster with the human architecture versus the rodent architecture,” he says.

There are many other differences between human neurons and those of other species, Harnett adds, making it difficult to tease out the effects of dendritic electrical properties. In future studies, he hopes to explore further the precise impact of these electrical properties, and how they interact with other unique features of human neurons to produce more computing power.

The research was funded by the National Sciences and Engineering Research Council of Canada, the Dana Foundation David Mahoney Neuroimaging Grant Program, and the National Institutes of Health.

Model helps robots navigate more like humans do

by Rob Matheson |

When moving through a crowd to reach some end goal, humans can usually navigate the space safely without thinking too much. They can learn from the behavior of others and note any obstacles to avoid. Robots, on the other hand, struggle with such navigational concepts.

MIT researchers have now devised a way to help robots navigate environments more like humans do. Their novel motion-planning model lets robots determine how to reach a goal by exploring the environment, observing other agents, and exploiting what they’ve learned before in similar situations. A paper describing the model was presented at this week’s IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS).

Popular motion-planning algorithms will create a tree of possible decisions that branches out until it finds good paths for navigation. A robot that needs to navigate a room to reach a door, for instance, will create a step-by-step search tree of possible movements and then execute the best path to the door, considering various constraints. One drawback, however, is these algorithms rarely learn: Robots can’t leverage information about how they or other agents acted previously in similar environments.

“Just like when playing chess, these decisions branch out until [the robots] find a good way to navigate. But unlike chess players, [the robots] explore what the future looks like without learning much about their environment and other agents,” says co-author Andrei Barbu, a researcher at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the Center for Brains, Minds, and Machines (CBMM) within MIT’s McGovern Institute. “The thousandth time they go through the same crowd is as complicated as the first time. They’re always exploring, rarely observing, and never using what’s happened in the past.”

The researchers developed a model that combines a planning algorithm with a neural network that learns to recognize paths that could lead to the best outcome, and uses that knowledge to guide the robot’s movement in an environment.

In their paper, “Deep sequential models for sampling-based planning,” the researchers demonstrate the advantages of their model in two settings: navigating through challenging rooms with traps and narrow passages, and navigating areas while avoiding collisions with other agents. A promising real-world application is helping autonomous cars navigate intersections, where they have to quickly evaluate what others will do before merging into traffic. The researchers are currently pursuing such applications through the Toyota-CSAIL Joint Research Center.

“When humans interact with the world, we see an object we’ve interacted with before, or are in some location we’ve been to before, so we know how we’re going to act,” says Yen-Ling Kuo, a PhD student in CSAIL and first author on the paper. “The idea behind this work is to add to the search space a machine-learning model that knows from past experience how to make planning more efficient.”

Boris Katz, a principal research scientist and head of the InfoLab Group at CSAIL, is also a co-author on the paper.

Trading off exploration and exploitation

Traditional motion planners explore an environment by rapidly expanding a tree of decisions that eventually blankets an entire space. The robot then looks at the tree to find a way to reach the goal, such as a door. The researchers’ model, however, offers “a tradeoff between exploring the world and exploiting past knowledge,” Kuo says.

The learning process starts with a few examples. A robot using the model is trained on a few ways to navigate similar environments. The neural network learns what makes these examples succeed by interpreting the environment around the robot, such as the shape of the walls, the actions of other agents, and features of the goals. In short, the model “learns that when you’re stuck in an environment, and you see a doorway, it’s probably a good idea to go through the door to get out,” Barbu says.

The model combines the exploration behavior from earlier methods with this learned information. The underlying planner, called RRT*, was developed by MIT professors Sertac Karaman and Emilio Frazzoli. (It’s a variant of a widely used motion-planning algorithm known as Rapidly-exploring Random Trees, or  RRT.) The planner creates a search tree while the neural network mirrors each step and makes probabilistic predictions about where the robot should go next. When the network makes a prediction with high confidence, based on learned information, it guides the robot on a new path. If the network doesn’t have high confidence, it lets the robot explore the environment instead, like a traditional planner.

For example, the researchers demonstrated the model in a simulation known as a “bug trap,” where a 2-D robot must escape from an inner chamber through a central narrow channel and reach a location in a surrounding larger room. Blind allies on either side of the channel can get robots stuck. In this simulation, the robot was trained on a few examples of how to escape different bug traps. When faced with a new trap, it recognizes features of the trap, escapes, and continues to search for its goal in the larger room. The neural network helps the robot find the exit to the trap, identify the dead ends, and gives the robot a sense of its surroundings so it can quickly find the goal.

Results in the paper are based on the chances that a path is found after some time, total length of the path that reached a given goal, and how consistent the paths were. In both simulations, the researchers’ model more quickly plotted far shorter and consistent paths than a traditional planner.

“This model is interesting because it allows a motion planner to adapt to what it sees in the environment,” says Stephanie Tellex, an assistant professor of computer science at Brown University, who was not involved in the research. “This can enable dramatic improvements in planning speed by customizing the planner to what the robot knows. Most planners don’t adapt to the environment at all. Being able to traverse long, narrow passages is notoriously difficult for a conventional planner, but they can solve it. We need more ways that bridge this gap.”

Working with multiple agents

In one other experiment, the researchers trained and tested the model in navigating environments with multiple moving agents, which is a useful test for autonomous cars, especially navigating intersections and roundabouts. In the simulation, several agents are circling an obstacle. A robot agent must successfully navigate around the other agents, avoid collisions, and reach a goal location, such as an exit on a roundabout.

“Situations like roundabouts are hard, because they require reasoning about how others will respond to your actions, how you will then respond to theirs, what they will do next, and so on,” Barbu says. “You eventually discover your first action was wrong, because later on it will lead to a likely accident. This problem gets exponentially worse the more cars you have to contend with.”

Results indicate that the researchers’ model can capture enough information about the future behavior of the other agents (cars) to cut off the process early, while still making good decisions in navigation. This makes planning more efficient. Moreover, they only needed to train the model on a few examples of roundabouts with only a few cars. “The plans the robots make take into account what the other cars are going to do, as any human would,” Barbu says.

Going through intersections or roundabouts is one of the most challenging scenarios facing autonomous cars. This work might one day let cars learn how humans behave and how to adapt to drivers in different environments, according to the researchers. This is the focus of the Toyota-CSAIL Joint Research Center work.

“Not everybody behaves the same way, but people are very stereotypical. There are people who are shy, people who are aggressive. The model recognizes that quickly and that’s why it can plan efficiently,” Barbu says.

More recently, the researchers have been applying this work to robots with manipulators that face similarly daunting challenges when reaching for objects in ever-changing environments.

Recognizing the partially seen

by Kris Brewer |

When we open our eyes in the morning and take in that first scene of the day, we don’t give much thought to the fact that our brain is processing the objects within our field of view with great efficiency and that it is compensating for a lack of information about our surroundings — all in order to allow us to go about our daily functions. The glass of water you left on the nightstand when preparing for bed is now partially blocked from your line of sight by your alarm clock, yet you know that it is a glass.

This seemingly simple ability for humans to recognize partially occluded objects — defined in this situation as the effect of one object in a 3-D space blocking another object from view — has been a complicated problem for the computer vision community. Martin Schrimpf, a graduate student in the DiCarlo lab in the Department of Brain and Cognitive Sciences at MIT, explains that machines have become increasingly adept at recognizing whole items quickly and confidently, but when something covers part of that item from view, this task becomes increasingly difficult for the models to accurately recognize the article.

“For models from computer vision to function in everyday life, they need to be able to digest occluded objects just as well as whole ones — after all, when you look around, most objects are partially hidden behind another object,” says Schrimpf, co-author of a paper on the subject that was recently published in the Proceedings of the National Academy of Sciences (PNAS).

In the new study, he says, “we dug into the underlying computations in the brain and then used our findings to build computational models. By recapitulating visual processing in the human brain, we are thus hoping to also improve models in computer vision.”

How are we as humans able to repeatedly do this everyday task without putting much thought and energy into this action, identifying whole scenes quickly and accurately after injesting just pieces? Researchers in the study started with the human visual cortex as a model for how to improve the performance of machines in this setting, says Gabriel Kreiman, an affiliate of the MIT Center for Brains, Minds, and Machines. Kreinman is a professor of ophthalmology at Boston Children’s Hospital and Harvard Medical School and was lead principal investigator for the study.

In their paper, “Recurrent computations for visual pattern completion,” the team showed how they developed a computational model, inspired by physiological and anatomical constraints, that was able to capture the behavioral and neurophysiological observations during pattern completion. In the end, the model provided useful insights towards understanding how to make inferences from minimal information.

Work for this study was conducted at the Center for Brains, Minds and Machines within the McGovern Institute for Brain Research at MIT.

Feng Zhang wins 2018 Keio Medical Science Prize

Anne Trafton |

Molecular biologist Feng Zhang has been named a winner of the prestigious Keio Medical Science Prize. He is being recognized for the groundbreaking development of CRISPR-Cas9-mediated genome engineering in cells and its application for medical science.

Zhang is the James and Patricia Poitras Professor of Neuroscience at MIT, an associate professor in the departments of Brain and Cognitive Sciences and Biological Engineering, a Howard Hughes Medical Institute investigator, an investigator at the McGovern Institute for Brain Research, and a core member of the Broad Institute of MIT and Harvard.

“We are delighted that Feng is now a Keio Prize laureate,” says McGovern Institute Director Robert Desimone. “This truly recognizes the remarkable achievements that he has made at such a young age.”

Zhang is a molecular biologist who has contributed to the development of multiple molecular tools to accelerate the understanding of human disease and create new therapeutic modalities. During his graduate work, Zhang contributed to the development of optogenetics, a system for activating neurons using light, which has advanced our understanding of brain connectivity.

Zhang went on to pioneer the deployment of the microbial CRISPR-Cas9 system for genome engineering in eukaryotic cells. The ease and specificity of the system has led to its widespread use across the life sciences and it has groundbreaking implications for disease therapeutics, biotechnology, and agriculture. He has continued to mine bacterial CRISPR systems for additional enzymes with useful properties, leading to the discovery of Cas13, which targets RNA, rather than DNA, and may potentially be a way to treat genetic diseases without altering the genome. Zhang has also developed a molecular detection system called SHERLOCK based on the Cas13 family, which can sense trace amounts of genetic material, including viruses and alterations in genes that might be linked to cancer.

“I am tremendously honored to have our work recognized by the Keio Medical Prize,” says Zhang. “It is an inspiration to us to continue our work to improve human health.”

Now in its 23rd year, the Keio Medical Science Prize is awarded to a maximum of two scientists each year. The other 2018 laureate, Masashi Yanagisawa, director of the International Institute for Integrative Sleep Medicine at the University of Tsukuba, is being recognized for his seminal work on sleep control mechanisms.

The prize is offered by Keio University, and the selection committee specifically looks for laureates that have made an outstanding contribution to medicine or the life sciences. The prize was initially endowed by Mitsunada Sakaguchi in 1994, with the express condition that it be used to commend outstanding science, promote advances in medicine and the life sciences, expand researcher networks, and contribute to the wellbeing of humankind. The winners receive a certificate of merit, a medal, and a monetary award of approximately $90,000.

The prize ceremony will be held on Dec. 18 at Keio University in Tokyo.

Mark Harnett named Vallee Foundation Scholar

Anne Trafton |

The Bert L and N Kuggie Vallee Foundation has named McGovern Institute investigator Mark Harnett a 2018 Vallee Scholar. The Vallee Scholars Program recognizes original, innovative, and pioneering work by early career scientists at a critical juncture in their careers and provides $300,000 in discretionary funds to be spent over four years for basic biomedical research. Harnett is among five researchers named to this year’s Vallee Scholars Program.

Harnett, who is also the Fred and Carole Middleton Career Development Assistant Professor in the Department of Brain and Cognitive Sciences, is being recognized for his work exploring how the biophysical features of neurons give rise to the computational power of the brain. By exploiting new technologies and approaches at the interface of biophysics and systems neuroscience, research in the Harnett lab aims to provide a new understanding of the biology underlying how mammalian brains learn. This may open new areas of research into brain disorders characterized by atypical learning and memory (such as dementia and schizophrenia) and may also have important implications for designing new, brain-inspired artificial neural networks.

The Vallee Foundation was established in 1996 by Bert and Kuggie Vallee to foster originality, creativity, and leadership within biomedical scientific research and medical education. The foundation’s goal to fund originality, innovation, and pioneering work “recognizes the future promise of these scientists who are dedicated to understanding fundamental biological processes.” Harnett joins a list of 24 Vallee Scholars, including McGovern investigator Feng Zhang, who have been appointed to the program since its inception in 2013.

New sensors track dopamine in the brain for more than a year

Anne Trafton |

Dopamine, a signaling molecule used throughout the brain, plays a major role in regulating our mood, as well as controlling movement. Many disorders, including Parkinson’s disease, depression, and schizophrenia, are linked to dopamine deficiencies.

MIT neuroscientists have now devised a way to measure dopamine in the brain for more than a year, which they believe will help them to learn much more about its role in both healthy and diseased brains.

“Despite all that is known about dopamine as a crucial signaling molecule in the brain, implicated in neurologic and neuropsychiatric conditions as well as our ability to learn, it has been impossible to monitor changes in the online release of dopamine over time periods long enough to relate these to clinical conditions,” says Ann Graybiel, an MIT Institute Professor, a member of MIT’s McGovern Institute for Brain Research, and one of the senior authors of the study.

Michael Cima, the David H. Koch Professor of Engineering in the Department of Materials Science and Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research, and Rober Langer, the David H. Koch Institute Professor and a member of the Koch Institute, are also senior authors of the study. MIT postdoc Helen Schwerdt is the lead author of the paper, which appears in the Sept. 12 issue of Communications Biology.

Long-term sensing

Dopamine is one of many neurotransmitters that neurons in the brain use to communicate with each other. Traditional systems for measuring dopamine — carbon electrodes with a shaft diameter of about 100 microns — can only be used reliably for about a day because they produce scar tissue that interferes with the electrodes’ ability to interact with dopamine.

In 2015, the MIT team demonstrated that tiny microfabricated sensors could be used to measure dopamine levels in a part of the brain called the striatum, which contains dopamine-producing cells that are critical for habit formation and reward-reinforced learning.

Because these probes are so small (about 10 microns in diameter), the researchers could implant up to 16 of them to measure dopamine levels in different parts of the striatum. In the new study, the researchers wanted to test whether they could use these sensors for long-term dopamine tracking.

“Our fundamental goal from the very beginning was to make the sensors work over a long period of time and produce accurate readings from day to day,” Schwerdt says. “This is necessary if you want to understand how these signals mediate specific diseases or conditions.”

To develop a sensor that can be accurate over long periods of time, the researchers had to make sure that it would not provoke an immune reaction, to avoid the scar tissue that interferes with the accuracy of the readings.

The MIT team found that their tiny sensors were nearly invisible to the immune system, even over extended periods of time. After the sensors were implanted, populations of microglia (immune cells that respond to short-term damage), and astrocytes, which respond over longer periods, were the same as those in brain tissue that did not have the probes inserted.

In this study, the researchers implanted three to five sensors per animal, about 5 millimeters deep, in the striatum. They took readings every few weeks, after stimulating dopamine release from the brainstem, which travels to the striatum. They found that the measurements remained consistent for up to 393 days.

“This is the first time that anyone’s shown that these sensors work for more than a few months. That gives us a lot of confidence that these kinds of sensors might be feasible for human use someday,” Schwerdt says.

Paul Glimcher, a professor of physiology and neuroscience at New York University, says the new sensors should enable more researchers to perform long-term studies of dopamine, which is essential for studying phenomena such as learning, which occurs over long time periods.

“This is a really solid engineering accomplishment that moves the field forward,” says Glimcher, who was not involved in the research. “This dramatically improves the technology in a way that makes it accessible to a lot of labs.”

Monitoring Parkinson’s

If developed for use in humans, these sensors could be useful for monitoring Parkinson’s patients who receive deep brain stimulation, the researchers say. This treatment involves implanting an electrode that delivers electrical impulses to a structure deep within the brain. Using a sensor to monitor dopamine levels could help doctors deliver the stimulation more selectively, only when it is needed.

The researchers are now looking into adapting the sensors to measure other neurotransmitters in the brain, and to measure electrical signals, which can also be disrupted in Parkinson’s and other diseases.

“Understanding those relationships between chemical and electrical activity will be really important to understanding all of the issues that you see in Parkinson’s,” Schwerdt says.

The research was funded by the National Institute of Biomedical Imaging and Bioengineering, the National Institute of Neurological Disorders and Stroke, the Army Research Office, the Saks Kavanaugh Foundation, the Nancy Lurie Marks Family Foundation, and Dr. Tenley Albright.

Neuroscientists get at the roots of pessimism

Anne Trafton |

Many patients with neuropsychiatric disorders such as anxiety or depression experience negative moods that lead them to focus on the possible downside of a given situation more than the potential benefit.

MIT neuroscientists have now pinpointed a brain region that can generate this type of pessimistic mood. In tests in animals, they showed that stimulating this region, known as the caudate nucleus, induced animals to make more negative decisions: They gave far more weight to the anticipated drawback of a situation than its benefit, compared to when the region was not stimulated. This pessimistic decision-making could continue through the day after the original stimulation.

The findings could help scientists better understand how some of the crippling effects of depression and anxiety arise, and guide them in developing new treatments.

“We feel we were seeing a proxy for anxiety, or depression, or some mix of the two,” says Ann Graybiel, an MIT Institute Professor, a member of MIT’s McGovern Institute for Brain Research, and the senior author of the study, which appears in the Aug. 9 issue of Neuron. “These psychiatric problems are still so very difficult to treat for many individuals suffering from them.”

The paper’s lead authors are McGovern Institute research affiliates Ken-ichi Amemori and Satoko Amemori, who perfected the tasks and have been studying emotion and how it is controlled by the brain. McGovern Institute researcher Daniel Gibson, an expert in data analysis, is also an author of the paper.

Emotional decisions

Graybiel’s laboratory has previously identified a neural circuit that underlies a specific kind of decision-making known as approach-avoidance conflict. These types of decisions, which require weighing options with both positive and negative elements, tend to provoke a great deal of anxiety. Her lab has also shown that chronic stress dramatically affects this kind of decision-making: More stress usually leads animals to choose high-risk, high-payoff options.

In the new study, the researchers wanted to see if they could reproduce an effect that is often seen in people with depression, anxiety, or obsessive-compulsive disorder. These patients tend to engage in ritualistic behaviors designed to combat negative thoughts, and to place more weight on the potential negative outcome of a given situation. This kind of negative thinking, the researchers suspected, could influence approach-avoidance decision-making.

To test this hypothesis, the researchers stimulated the caudate nucleus, a brain region linked to emotional decision-making, with a small electrical current as animals were offered a reward (juice) paired with an unpleasant stimulus (a puff of air to the face). In each trial, the ratio of reward to aversive stimuli was different, and the animals could choose whether to accept or not.

This kind of decision-making requires cost-benefit analysis. If the reward is high enough to balance out the puff of air, the animals will choose to accept it, but when that ratio is too low, they reject it. When the researchers stimulated the caudate nucleus, the cost-benefit calculation became skewed, and the animals began to avoid combinations that they previously would have accepted. This continued even after the stimulation ended, and could also be seen the following day, after which point it gradually disappeared.

This result suggests that the animals began to devalue the reward that they previously wanted, and focused more on the cost of the aversive stimulus. “This state we’ve mimicked has an overestimation of cost relative to benefit,” Graybiel says.

The study provides valuable insight into the role of the basal ganglia (a region that includes the caudate nucleus) in this type of decision-making, says Scott Grafton, a professor of neuroscience at the University of California at Santa Barbara, who was not involved in the research.

“We know that the frontal cortex and the basal ganglia are involved, but the relative contributions of the basal ganglia have not been well understood,” Grafton says. “This is a nice paper because it puts some of the decision-making process in the basal ganglia as well.”

A delicate balance

The researchers also found that brainwave activity in the caudate nucleus was altered when decision-making patterns changed. This change, discovered by Amemori, is in the beta frequency and might serve as a biomarker to monitor whether animals or patients respond to drug treatment, Graybiel says.

Graybiel is now working with psychiatrists at McLean Hospital to study patients who suffer from depression and anxiety, to see if their brains show abnormal activity in the neocortex and caudate nucleus during approach-avoidance decision-making. Magnetic resonance imaging (MRI) studies have shown abnormal activity in two regions of the medial prefrontal cortex that connect with the caudate nucleus.

The caudate nucleus has within it regions that are connected with the limbic system, which regulates mood, and it sends input to motor areas of the brain as well as dopamine-producing regions. Graybiel and Amemori believe that the abnormal activity seen in the caudate nucleus in this study could be somehow disrupting dopamine activity.

“There must be many circuits involved,” she says. “But apparently we are so delicately balanced that just throwing the system off a little bit can rapidly change behavior.”

The research was funded by the National Institutes of Health, the CHDI Foundation, the U.S. Office of Naval Research, the U.S. Army Research Office, MEXT KAKENHI, the Simons Center for the Social Brain, the Naito Foundation, the Uehara Memorial Foundation, Robert Buxton, Amy Sommer, and Judy Goldberg.

Michale Fee receives McKnight Technological Innovations in Neuroscience Award

by Julie Pryor |

McGovern Institute investigator Michale Fee has been selected to receive a 2018 McKnight Technological Innovations in Neuroscience Award for his research on “new technologies for imaging and analyzing neural state-space trajectories in freely-behaving small animals.”

“I am delighted to get support from the McKnight Foundation,” says Fee, who is also the Glen V. and Phyllis F. Dorflinger Professor in the Department of Brain and Cognitive Neurosciences at MIT. “We’re very excited about this project which aims to develop technology that will be a great help to the broader neuroscience community.”

Fee studies the neural mechanisms by which the brain, specifically that of juvenile songbirds, learns complex sequential behaviors. The way that songbirds learn a song through trial and error is analogous to humans learning complex behaviors, such as riding a bicycle. While it would be insightful to link such learning to neural activity, current methods for monitoring neurons can only monitor a limited field of neurons, a big issue since such learning and behavior involve complex interactions between larger circuits. While a wider field of view for recordings would help decipher neural changes linked to this learning paradigm, current microscopy equipment is large relative to a juvenile songbird, and microscopes that can record neural activity generally constrain the behavior of small animals. Ideally, technologies need to be lightweight (about 1 gram) and compact in size (the size of a dime), a far cry from current larger microscopes that weigh in at 3 grams. Fee hopes to be able to break these technical boundaries and miniaturize the recording equipment thus allowing recording of more neurons in naturally behaving small animals.

“We are thrilled that the McKnight Foundation has chosen to support this project. The technology that Michale’s developing will help to better visualize and understand the circuits underlying learning,” says Robert Desimone, director of MIT’s McGovern Institute for Brain Research.

In addition to development and miniaturization of the microscopy hardware itself, the award will support the development of technology that helps analyze the resulting images, so that the neuroscience community at large can more easily deploy and use the technology.

Advancing knowledge in medical and genetic sciences

Anne Trafton |

Research proposals from Laurie Boyer, associate professor of biology; Matt Shoulders, the Whitehead Career Development Associate Professor of Chemistry; and Feng Zhang, associate professor in the departments of Brain and Cognitive Sciences and Biological Engineering, Patricia and James Poitras ’63 Professor in Neuroscience, investigator at the McGovern Institute for Brain Research, and core member of the Broad Institute, have recently been selected for funding by the G. Harold and Leila Y. Mathers Foundation. These three grants from the Mathers Foundation will enable, over the next three years, key projects in the researchers’ respective labs.

Regenerative medicine holds great promise for treating heart failure, but that promise is unrealized, in part, due to a lack of sufficient understanding of heart development at the mechanistic level. Boyer’s research aims to achieve a deep, mechanistic understanding of the gene control switches that coordinate normal heart development. She then aims to leverage this knowledge and design effective strategies for rewiring faulty circuits in aging and disease.

“We are very grateful to receive support and recognition of our work from the Mathers Foundation,” said Boyer. “This award will allow us to build upon our prior work and to embark upon high risk projects that could ultimately change how we think about treating diseases resulting from faulty wiring of gene expression programs.”

Shoulders’ goal, with this support from the Mathers Foundation, is to elucidate underlying causes of osteoarthritis. There is currently no cure for osteoarthritis, which is perhaps the most common aging-related disease and is characterized by a progressive deterioration of joint cartilage culminating in inflammation, debilitating pain, and joint dysfunction. The Shoulders Group aims to test a new model for osteoarthritis — specifically, the concept that a collapse of proteostasis in aging cartilage cells creates an unrecoverable cartilage repair defect, thus initiating a self-amplifying, destructive feedback loop leading to pathology. Proteostasis collapse in aging cells is a well-known, disease-causing phenomenon that has previously been considered primarily in the context of neurodegenerative disorders. If correct, the proteostasis collapse model for osteoarthritis could one day lead to a novel class of therapeutic options for the disease.

“We are delighted to receive this generous support from the Mathers Foundation, which makes it possible for us to pursue an outside-the-box, high-risk/high-impact idea regarding the origins of osteoarthritis,” said Shoulders. “The research we are now able to pursue will not only provide fundamental, molecular-level insights into joint function, but also could change how we think about this widespread disease.”

Many genetic diseases are caused by the change of just a single base of DNA. Zhang is a leader in the field of genome editing, and he and his team have developed an array of tools based on the microbial immune CRISPR-Cas systems that can manipulate DNA and RNA in human cells. Together, these tools are changing the way molecular biology research is conducted, and they hold immense potential as therapeutic agents to correct thousands of genetic diseases. Now, with the support of the Mathers Foundation, Zhang is working to realize this potential by developing a CRISPR-based therapeutic that works at the level of RNA and offers a safe, effective route to treating a range of diseases, including diseases of the brain and central nervous system, which are difficult to treat with existing gene therapies.

“The generous support from the Mathers Foundation allows us the freedom to explore this exciting new direction for CRISPR-based technologies,” Zhang stated.

Known for their generosity and philanthropy, G. Harold and Leila Y. Mathers created their foundation with the goal of distributing their wealth among sustainable, charitable causes, with a particular interest in basic scientific research. The Mathers Foundation, whose ongoing mission is to advance knowledge in the life sciences by sponsoring scientific research and applying learnings and discoveries to benefit mankind, has issued grants since 1982.